Na+-dependent metabolic coupling upon 5-HT(1B) receptor activation by sumatriptan and related agonists

Receptors and Channels

Volumn 5, Issue 6, 1998, Pages 367-373

  Pauwels, Petrus J ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

CHO K1 cells; h5 HT(1B) receptor; Metabolic rate; Sumatriptan

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; GLUCOSE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NEUROPEPTIDE; PERTUSSIS TOXIN; SEROTONIN 1B RECEPTOR; SEROTONIN AGONIST; SODIUM ION; SUMATRIPTAN;

ANIMAL CELL; ARTICLE; BRAIN BLOOD VESSEL; CELL ENERGY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DURA MATER; INFLAMMATION; METABOLIC RATE; MIGRAINE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; VASOCONSTRICTION;

ANIMALS; CHO CELLS; CRICETINAE; OXADIAZOLES; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SODIUM; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

ANIMALIA;

EID: 0031772523     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beer MS Stanton JA Bevan Y Heald A Reeve AJ Street LJ Matassa VG Hargreaves RJ and Middlemiss DN (1993) Br J Pharmacol 110 1196-1200
2. Caekebeke JFV Ferrari MD Zwetsloot CP Jansen J and Saxena PR (1992) Neurology 42 1522-1526
3. Clitherow JW Scopes DIC Skingle M Jordan CC Feniuk W Campbell IB Carter MC Collington EW Connor HE Higgins GA Beattie D Kelly HA Mitchell WL Oxford AW Wadsworth AH and Tyers MB (1994) J Med Chem 37 2251-2257
4. Ferrari MD and Saxena PR (1993) Trends Pharmacol Sci 14 129-133
5. Frelin C Barbry P Vigne P Chassande O Cragoe JE and Lazdunski M (1988) Biochimie 70 1285-1290
6. Friberg L Olesen J Iversen HK and Sperling B (1991) Lancet 338 13-17
7. Gamovskaya MN Gettys TW Van Biesen T Prpic V Chuprun JK and Raymond JR (1997) J Biol Chem 272 7770-7776
8. Goadsby PJ Edvinsson L and Ekman R (1988) Ann Neurol 23 193-196
9. Goadsby PJ and Edvinsson L (1993) Ann Neurol 33 48-56
10. Hoskin KL Kaube H and Goadsby PJ (1996) Brain 119 249-256
11. Humphrey PPA Feniuk W Perren MJ Connor HE Oxford AW Coates IH and Butina D (1988) Br J Pharmacol 94 1123-1132
12. Leonard BE (1992) Int Clin Psychopharmacol 7 13-21
13. Mac Dermott AB and Weight FF (1982) Nature 300 185-188
14. Martin GR (1996) Eur Neurol 36 13-18
15. McConnell HM Owicki JC Parce JW Miller DL Baxter GT Wada HG and Pitchford S (1992) Science 257 1906-1912
16. Moskowitz MA (1991) Neurology 41 182-186
17. Pardee AB (1968) Science 162 632-637
18. Pauwels PJ and Colpaert FC (1995) Neuropharmacology 34 235-237
19. Pauwels PJ and Palmier C (1995) Eur J Pharmacol Mol Pharmacol Section 290 95-103
20. Sah P (1996) Trends Neurosci 19 150-154
21. Sandler M (1995) Cephalalgia 15 259-264
22. Seuwen K Magnaldo I and Pouysségur C (1988) Nature 335 254-256
23. Street LJ Baker R Davey WB Guiblin AR Jelley RA Reeve AJ Routledge H Sternfeld F Watt AP Beer M S Middlemiss DN Noble AJ Stanton JA Scholey K Hargreaves RJ Sohal B Graham MI and Matassa VG (1995) J Med Chem 38 1799-1810
24. Vigne P Jean T Barbry P Frelin C Fine LG and Lazdunski M (1985) J Biol Chem 26 14120-14125
25. Wantanabe H Kuwabara T Ohkubo M Tsuji S and Yuasa T (1996) Neurology 47 1093-1095
26. Weinshank RL Zgombick JM Macchi MJ Branchek TA and Hartig PR (1992) Proc Natl Acad Sci 89 3630-3634